JPRN-UMIN000007281招募中未知
Safety and efficacy of reduced intensity myeloablative conditioning regimen with fludarabine, cytarabine arabinoside, and cyclophosphamide for hematological malignancies - GHSG-SCT1101
Gifu University Hospital0 个研究点目标入组 36 人开始时间: 2012年2月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with HIV 2) Patients who received gemtuzumab ozogamicin within 3 months 3) Patients with another active malignancy 4) Patients with severe mental disease 5) Patients with severe central nervous system (CNS) lesions (except for CNS lesions of the underlying disease) 6) Patients with active infection 7) Patients who have history of chemotherapy within 21 days before transplantation (except hydroxyurea, cytarabine, or etoposide therapy for blast control) 8) Patients who have hypersensitivity to drugs included in this protocol 9) Patients who are judged inappropriate for the entry into the study by the principle doctor.
研究者
相似试验
已完成
2 期
Safety and efficacy of reduced-intensity myeloablative conditioning regimen with fludarabine and intravenous busulfan for hematological malignanciesHematological malignanciesJPRN-UMIN000006540niversity of Tsukuba, Department of Hematology10
招募中
3 期
Comparison of conditioning regimens before Hematopoietic Cell Transplantation in patients with Acute Leukemia.Condition 1: Acute Myeloblastic leukemia. Condition 2: Myelodysplastic Syndromes. Condition 3: Acute Lymphoblastic Leukemia.Myelodysplastic syndromesAcute lymphoblastic leukemia [ALL]C92.0C91.0Acute myeloblastic leukemiaIRCT20140818018842N25Tehran University of Medical Sciences84
招募中
2 期
Haplo-RIC in KakogawaLymphoma, leukemia, hematological malignancy018 019 020Hematological malignancyJPRN-jRCTs051180119Okamura Atsuo23
招募中
2 期
Haplo-MAC in KakogawaLymphoma, leukemia, hematological malignancy018 019 020Hematological malignancyJPRN-jRCTs051180118Okamura Atsuo25
已完成
3 期
Evaluating safety and efficacy of low dose monteplase and nicorandil injected before percutaneous coronary intervention on left ventricular wall motion in patients of acute myocardial infarction:a randomized study.Acute myocardial infarctionJPRN-C000000229Chiba Emergency Medical Center88